Tel Aviv, Israel

Oded Rechavi

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Oded Rechavi: Innovator in Protein Delivery Systems

Introduction

Oded Rechavi is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of innovative methods for delivering proteins to the central nervous system (CNS). With a total of 2 patents, his work is paving the way for new therapeutic approaches.

Latest Patents

Rechavi's latest patents focus on engineered parasites for delivering proteins to the CNS. The first patent provides nucleic acid constructs and pharmaceutical compositions that facilitate the delivery of a protein-of-interest to a tissue-of-interest, such as the CNS. This method aims to treat pathologies that can be addressed through the administration of therapeutic polypeptides in the central nervous system. The second patent also centers on engineered parasites, specifically Toxoplasma, for similar applications in delivering proteins to the CNS.

Career Highlights

Throughout his career, Oded Rechavi has worked with notable institutions, including Ramot at Tel Aviv University Ltd. and the University of Glasgow. His research has garnered attention for its potential impact on treating neurological disorders.

Collaborations

Rechavi has collaborated with several professionals in his field, including Shahar Bracha and Lilach Sheiner. These partnerships have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

Oded Rechavi's innovative work in protein delivery systems represents a significant advancement in biotechnology. His patents and collaborations highlight his commitment to improving therapeutic options for patients with central nervous system pathologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…